NVAX
NASDAQ HealthcareNovavax, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $10.30 |
|---|---|
| Volume | 3,539,091 |
| Market Cap | 1.68B |
| Beta | 2.630 |
| RSI (14-Day) | 60.0 |
| 200-Day MA | $7.88 |
| 50-Day MA | $8.88 |
| 52-Week High | $11.97 |
| 52-Week Low | $5.01 |
| P/E Ratio | 3.99 |
| Forward P/E | -18.10 |
| Price / Book | -13.10 |
🎯 Investment Strategy Scores
How NVAX scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
2/100
High dividend yield + low volatility
🚀 Moon Shot
94/100
High growth potential (high beta + oversold)
🔪 Falling Knife
8/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
86/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
36/100
Large-cap, institutional-quality stocks
Find NVAX in your text
Paste any text on the homepage — the tool will extract NVAX and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.